EX-10.5



 Exhibit 10.5 

TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

ADOPTED BY BOARD: [            ],
2014 
 APPROVED BY STOCKHOLDERS:
[            ], 2014 
 EFFECTIVE
DATE/INITIAL PUBLIC OFFERING DATE: [            ], 2014 

 

	1.	PURPOSES. 

 (a) Available Awards. The purpose of the Plan is to
provide a means by which eligible recipients of Awards may be given an opportunity to benefit from increases in value of the Common Stock through the granting of the following Awards: (i) an Option (as defined herein), (ii) restricted
stock awards, (iii) stock appreciation rights, (iv) restricted stock units, (v) performance shares, (vi) stock bonuses and (vii) other share-based awards. 

(b) General Purpose. The Company, by means of the Plan, seeks to retain the services of the group of persons eligible to receive
Awards, to secure and retain the services of new members of this group and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Affiliates. 

 

	2.	DEFINITIONS. 

 (a) “Affiliate” means any
parent corporation or subsidiary corporation of the Company, whether now or hereafter existing, as those terms are defined in Sections 424(e) and (f), respectively, of the Code. 

(b) “Award” means any right granted under the Plan, including an Option, restricted stock awards, stock
appreciation rights, restricted stock units, performance shares, stock bonuses and other share-based awards. 
 (c) “Award
Agreement” means a written agreement between the Company and a holder of an Award evidencing the terms and conditions of an individual Award grant. Each Award Agreement shall be subject to the terms and conditions of the Plan. 

(d) “Board” means the board of directors of the Company; provided, however, that if the Board delegates
administration of the Plan to a committee pursuant to Section 3(c), then any reference to the Board in relationship to administration of the Plan or any Award Agreement shall be deemed to refer to such committee as applicable. 

(e) “Capitalization Adjustment” has the meaning ascribed to that term in Section 11(a). 

(f) “Cause” means, with respect to any Participant, the occurrence of any one or more of the following:
(i) a material breach by a Participant of his or her contractual obligations to the Company concerning his or her employment or the Company’s written policies; (ii) gross negligence, serious misconduct or a material failure by a
Participant in connection with the discharge of his or her duties or otherwise relating to his or her employment by the Company; (iii) a Participant’s use of drugs or alcohol in such a manner as to materially interfere with the performance
of his or her duties; or (iv) the Participant’s conviction of, or a plea of no contest to, a felony or misdemeanor involving moral turpitude. 







 (g) “Code” means the Internal Revenue Code of 1986, as amended.

 (h) “Committee” means a committee of one or more members of the Board appointed by the Board in accordance
with Section 3(c). 
 (i) “Common Stock” means the common stock of the Company. 

(j) “Company” means TriVascular Technologies, Inc., a Delaware corporation. 

(k) “Consultant” means any person, including an advisor, (i) engaged by the Company or an Affiliate to
render consulting, independent contractor or advisory services and who is compensated for such services or (ii) serving as a member of the Board of Directors of an Affiliate and who is compensated for such services. However, the term
“Consultant” shall not include Directors who are not compensated by the Company for their services as Directors, and the payment of a director’s fee by the Company for services as a Director shall not cause a Director to be considered
a “Consultant” for purposes of the Plan. 
 (l) “Continuous Service” means that the
Participant’s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an
Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant’s service with the Company or an Affiliate, shall not terminate
a Participant’s Continuous Service. For example, a change in status from an employee of the Company to a consultant to an Affiliate or to a Director shall not constitute an interruption of Continuous Service. The Board or the Chief Executive
Officer of the Company, in that party’s sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other
personal leave. Notwithstanding the foregoing, a leave of absence shall be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company’s leave of absence policy or in the written terms
of the Participant’s leave of absence. 
 (m) “Corporate Transaction” means the occurrence, in a single
transaction or in a series of related transactions, of any one or more of the following events: 
 (i) a sale or other disposition of
all or substantially all of the consolidated assets of the Company and its Subsidiaries; 
 (ii) a sale or other disposition of at
least 50% of the outstanding securities of the Company; 
 (iii) a merger, consolidation or similar transaction following which the
Company is not the surviving corporation; or 
 (iv) a merger, consolidation or similar transaction following which the Company is
the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property,
whether in the form of securities, cash or otherwise. 

  
 2 








 To the extent necessary for compliance with Section 409A of the Code, an event shall not be
deemed a Corporate Transaction if it is not also a “change in the ownership or effective control” of the Company or a “change in the ownership of a substantial portion of the assets” of the Company as determined under Treasury
Regulation Section 1.409A-3(i)(5). 
 (n) “Director” means a member of the Board. 

(o) “Disability” means in the case of an Incentive Stock Option total and permanent disability as defined in
Section 22(e)(3) of the Code. In the case of other Awards, “Disability” means the inability of a person, in the opinion of a qualified physician acceptable to the Company, to perform the major duties of that person’s position
with the Company or an Affiliate because of the sickness or injury of the person. 
 (p) “Employee” means any
person employed by the Company or an Affiliate. Service as a Director or payment of a director’s fee by the Company for such service or for service as a member of the Board of Directors of an Affiliate shall not be sufficient to constitute
“employment” by the Company or an Affiliate. 
 (q) “Entity” means a corporation, partnership,
limited liability company or other entity. 
 (r) “Exchange Act” means the Securities Exchange Act of 1934,
as amended. 
 (s) “Exchange Act Person” means any natural person, Entity or “group” (within the
meaning of Section 13(d) or 14(d) of the Exchange Act), except that “Exchange Act Person” shall not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of
the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to an offering of such securities or
(iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company. 

(t) “Fair Market Value” means, as of any date, the value of a share of the Company’s Common Stock
determined as follows: 
 (i) if such Common Stock is publicly traded and is then listed on a national securities exchange, its
closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in The Wall Street Journal or such other source as the Board deems reliable; 

(ii) if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the
average of the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the Board deems reliable; 

(iii) in the case of an Option or SAR grant made on the Effective Date, the price per share at which shares of the Company’s
Common Stock are initially offered for sale to the public by the Company’s underwriters in the initial public offering of the Company’s Common Stock pursuant to a registration statement filed with the Securities Exchange Commission under
the Securities Act; or 
 (iv) if none of the foregoing is applicable, by the Board in good faith. 

  
 3 








 (u) “Incentive Stock Option” means an Option intended to qualify
as an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder. 
 (v)
“Nonstatutory Stock Option” means an Option not intended to qualify as an Incentive Stock Option. 
 (w)
“Officer” means any person designated by the Company as an officer. 
 (x)
“Option” means an Incentive Stock Option or a Nonstatutory Stock Option granted pursuant to the Plan. 
 (y)
“Option Agreement” means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an individual Option grant. Each Option Agreement shall be subject to the terms and conditions of
the Plan. 
 (z) “Optionholder” means a person to whom an Option is granted pursuant to the Plan or, if
applicable, such other person who holds an outstanding Option. 
 (aa) “Own,” “Owned,” “Owner,”
“Ownership.” A person or Entity shall be deemed to “Own,” to have “Owned,” to be the “Owner” of, or to have acquired “Ownership” of securities if such person or Entity, directly or
indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. 

(bb) “Participant” means a person to whom an Award is granted pursuant to the Plan or, if applicable, such
other person who holds an outstanding Award. 
 (cc) “Performance Factors” means any of the factors selected
by the Board and specified in an Award Agreement, from among the following objective measures, either individually, alternatively or in any combination, applied to the Company as a whole or any business unit or Subsidiary, either individually,
alternatively, or in any combination, on a GAAP or non-GAAP basis, and measured, to the extent applicable on an absolute basis or relative to a pre-established target, to determine whether the performance goals established by the Board with respect
to applicable Awards have been satisfied: profit before tax; billings; revenue; net revenue; earnings (which may include earnings before interest and taxes, earnings before taxes, and net earnings); operating income; operating margin; operating
profit; controllable operating profit or net operating profit; net profit; gross margin; operating expenses or operating expenses as a percentage of revenue; net income; earnings per share; total stockholder return; market share; return on assets or
net assets; the company’s stock price; growth in stockholder value relative to a pre-determined index; return on equity; return on invested capital; cash flow (including free cash flow or operating cash flows); cash conversion cycle; economic
value added; individual confidential business objectives; contract awards or backlog; overhead or other expense reduction; credit rating; strategic plan development and implementation; succession plan development and implementation; improvement in
workforce diversity; customer indicators; new product invention or innovation; attainment of research and development milestones; improvements in productivity; bookings; attainment of objective operating goals and employee metrics; and any other
metric that is capable of measurement as determined by the Board. 

  
 4 








 The Board may, in recognition of unusual or non-recurring items such as acquisition-related
activities or changes in applicable accounting rules, provide for one or more equitable adjustments (based on objective standards) to the Performance Factors to preserve the Board’s original intent regarding the Performance Factors at the time
of the initial award grant. It is within the sole discretion of the Board to make or not make any such equitable adjustments. 
 (dd)
“Performance Period” means the period of service determined by the Board, during which years of service or performance is to be measured for the Award. 

(ee) “Performance Share” means a performance share bonus granted as a Performance Award. 

(ff) “Plan” means this TriVascular Technologies, Inc. 2014 Equity Incentive Plan. 

(gg) “SAR” means a stock appreciation right granted pursuant to Section 8(d). 

(hh) “Securities Act” means the Securities Act of 1933, as amended. 

(ii) “Subsidiary” means, with respect to the Company, (i) any corporation of which more than 50% of the
outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation shall have or might have voting
power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company and (ii) any partnership in which the Company has a direct or indirect interest (whether in the form of voting or participation in
profits or capital contribution) of more than 50%. 
 (jj) “Ten Percent Stockholder” means a person who Owns
(or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of any of its Affiliates. 

 

	3.	ADMINISTRATION. 

 (a) Administration by Board. The Board shall
administer the Plan unless and until the Board delegates administration to a Committee, as provided in Section 3(c). 
 (b) Powers
of Board. The Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan: 
 (i)
To determine from time to time which of the persons eligible under the Plan shall be granted Awards; when and how each Award shall be granted; what type or combination of types of Award shall be granted; the provisions of each Award granted
(which need not be identical), including the time or times when a person shall be permitted to receive Common Stock pursuant to a Award; and the number of shares of Common Stock with respect to which an Award shall be granted to each such person.

 (ii) To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for
its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully
effective. 

  
 5 








 (iii) To amend the Plan or an Award as provided in Section 12. 

(iv) To terminate or suspend the Plan as provided in Section 13. 

(v) Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests
of the Company and that are not in conflict with the provisions of the Plan. 
 (c) Delegation to Committee. The Board may delegate
administration of the Plan to a Committee or Committees, and the term “Committee” shall apply to any person or persons to whom such authority has been delegated. If administration is delegated to a Committee, the Committee shall have, in
connection with the administration of the Plan, the powers theretofore possessed by the Board, including the power to delegate to a subcommittee composed of one or more members of the Committee any of the administrative powers the Committee is
authorized to exercise (and references in this Plan to the Board shall thereafter be to the Committee or subcommittee, as applicable), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from
time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. 
 (d)
Delegation to an Officer. The Board may delegate to one or more Officers of the Company the authority to do one or both of the following: (i) designate Officers and Employees of the Company or any of its Subsidiaries to be recipients of
Awards and (ii) determine the number of shares of Common Stock to be subject to such Awards granted to such Officers and Employees of the Company; provided, however, that the Board resolutions regarding such delegation shall specify the
total number of shares of Common Stock that may be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself. Notwithstanding the foregoing, the Board may not delegate authority to an Officer to
determine the Fair Market Value of the Common Stock. 
 (e) Effect of Board’s Decision. All determinations, interpretations and
constructions made by the Board in good faith shall not be subject to review by any person and shall be final, binding and conclusive on all persons. 

(f) Section 162(m) of the Code and Section 16 of the Exchange Act. When necessary or desirable for an Award to qualify as
“performance-based compensation” under Section 162(m) of the Code, the Committee shall include at least two (2) persons who are “outside directors” (as defined under Section 162(m) of the Code) and at least two
(2) such “outside directors,” or a majority of such “outside directors” if more than two (2) such “outside directors” then serve on the Committee, shall approve the grant of such Award and timely determine (as
applicable) the Performance Period and any Performance Factors upon which vesting or settlement of any portion of such Award is to be subject. When required by Section 162(m) of the Code, prior to settlement of any such Award at least two
(2) such “outside directors” or a majority of such “outside directors” if more than two (2) such “outside directors” then serve on the Committee, shall determine and certify in writing the extent to which such
Performance Factors have been timely achieved and the extent to which the shares subject to such Award have thereby been earned. Awards granted to Participants who are subject to Section 16 of the Exchange Act must be approved by two
(2) or more “non-employee directors” (as defined in the regulations promulgated under Section 16 of the Exchange Act). With respect to Participants whose compensation 

  
 6 








 
is subject to Section 162(m) of the Code, and provided that such adjustments are consistent with the regulations promulgated under Section 162(m) of the Code, the Committee may adjust
the Performance Factors to account for changes in law and accounting and to make such adjustments as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or
hardships, including without limitation (i) restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring charges, (ii) an event either not directly related to the operations of the Company or not within
the reasonable control of the Company’s management or (iii) a change in accounting standards required by generally accepted accounting principles. 
  

	4.	SHARES SUBJECT TO THE PLAN. 


(a) Share Reserve. Subject to the provisions of Section 11(a) relating to Capitalization Adjustments and Sections 4(b) and
(c) below, the Common Stock that may be issued pursuant to Awards shall not exceed in the aggregate 2,750,000 shares of Common Stock. 

(b) Reversion of Shares to the Share Reserve. If an Award or any portion thereof (i) expires or otherwise terminates without all
of the shares covered by such Award having been issued or (ii) is settled in cash (i.e., the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of
shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to an Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition
required to vest such shares in the Participant, then the shares that are forfeited or repurchased will revert to and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax withholding
obligations on an Award or as consideration for the exercise or purchase price of an Award will again become available for issuance under the Plan. 

(c) Automatic Share Reserve Increase. The number of shares of Common Stock available for grant and issuance under the Plan shall be
increased on January 1 of each of the ten (10) calendar years during the term of the Plan, commencing on January 1st of the year following the year in which the IPO Date occurs and
ending on (and including) January 1, 2024, by the lesser of (i) four percent (4%) of the number of shares of Common Stock issued and outstanding on each December 31 immediately prior to the date of increase or (ii) such
number of shares of Common Stock determined by the Board prior to the start of the year to which such increase applies. 
 (d)
Limitations. Subject to the provisions of Section 11(a) relating to Capitalization Adjustments, no more than 8,000,000 shares of Common Stock shall be issued pursuant to the exercise of Incentive Stock Options. 

(e) Source of Shares. The shares of Common Stock subject to the Plan may be unissued shares or reacquired shares, bought on the market
or otherwise. 
  

	5.	ELIGIBILITY. 

 (a) Eligible Award Recipients. The persons eligible
to receive Awards are Employees, Directors and Consultants. 

  
 7 








 (b) Eligibility for Specific Awards. Incentive Stock Options may be granted only to
Employees. Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants. 
 (c) Ten Percent
Stockholders. A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value of the Common Stock on the date of grant and the Option is not exercisable
after the expiration of five (5) years from the date of grant. 
 (d) Individual Share Limitation. Subject to the provisions of
Section 11(a) relating to Capitalization Adjustments, no Participant shall be eligible to receive more than 1,000,000 shares of Common Stock in any calendar year under this Plan pursuant to the grant of Awards except that new Employees of
the Company or of an Affiliate of the Company (including new Employees who are also Officers and Directors of the Company or any Affiliate of the Company) are eligible to receive up to a maximum of 1,500,000 shares of Common Stock in the calendar
year in which they commence their employment. 
  

	6.	OPTION PROVISIONS. 

 Each Option shall be in such form and
shall contain such terms and conditions as the Board shall deem appropriate. All Options shall be designated Incentive Stock Options and/or Nonstatutory Stock Options at the time of grant. The provisions of separate Options need not be identical.

 (a) Term. Subject to the provisions of Section 5(c) regarding Ten Percent Stockholders, no Option shall be exercisable after
the expiration of ten (10) years from the date it was granted. 
 (b) Exercise Price of an Incentive Stock Option. Subject to
the provisions of Section 5(c) regarding Ten Percent Stockholders, the exercise price per share of each Incentive Stock Option shall be not less than 100% of the Fair Market Value on the date the Option is granted. Notwithstanding the
foregoing, an Incentive Stock Option may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the
provisions of Section 424(a) of the Code. 
 (c) Exercise Price of a Nonstatutory Stock Option. The exercise price per share of
each Nonstatutory Stock Option shall be not less than 100% of the Fair Market Value on the date the Option is granted. Notwithstanding the foregoing, a Nonstatutory Stock Option may be granted with an exercise price lower than that set forth in the
preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code. 

(d) Consideration. The purchase price of Common Stock acquired pursuant to an Option shall be paid in cash at the time the Option is
exercised; provided, however, that, to the extent permitted by applicable statutes and regulations, the Board may permit payment of the purchase price, in its sole discretion, determined at the time of the grant of the Option (or subsequently
in the case of a Nonstatutory Stock Option) by: (i) a deferred payment arrangement, (ii) delivery to the Company of other shares of Common Stock, (iii) pursuant to a net exercise and/or (iv) any other form of legal consideration
that may be acceptable to the Board. Unless otherwise specifically provided in the Option, the purchase price of Common Stock acquired pursuant to an Option that is paid, if so permitted, by delivery to the Company of other Common Stock acquired,
directly or indirectly from the Company, 

  
 8 








 
shall be paid only by shares of the Common Stock of the Company that have been held for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for
financial accounting purposes). 
 Except as otherwise determined by the Board, in the case of any deferred payment arrangement, interest
shall be compounded at least annually and shall be charged at the minimum rate of interest necessary to avoid (i) the treatment as interest, under any applicable provisions of the Code, of any amounts other than amounts stated to be interest
under the deferred payment arrangement and (ii) the treatment of the Option as a variable award for financial accounting purposes. 

In the case of a “net exercise” of an Option, the Company shall not require a payment of the exercise price from the Participant but
shall reduce the number of shares of Common Stock issued upon the exercise by the largest number of whole shares that has a Fair Market Value that does not exceed the aggregate exercise price. With respect to any remaining balance of the aggregate
exercise price, the Company shall accept a cash payment from the Participant. The shares of Common Stock so used to pay the exercise price under a “net exercise” shall be considered to have resulted from the exercise of the Option, and
accordingly, the Option shall not again be exercisable with respect to such shares, the shares actually delivered to the Participant, and any shares withheld for purposes of tax withholding. 

(e) Transferability of Options. The Board may, in its sole discretion, impose such limitations on the transferability of Options as the
Board shall determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options shall apply: 

(i) Restrictions on Transfer. An Option shall not be transferable except by will or by the laws of descent and distribution (or
pursuant to subsection (ii) and (iii) below), and shall be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option in a manner that is not prohibited by applicable tax and
securities laws. Except as explicitly provided herein, an Option may not be transferred for consideration. 
 (ii) Domestic Relations
Orders. Subject to the approval of the Board or a duly authorized Officer, an Option may be transferred pursuant to the terms of a domestic relations order or official marital settlement agreement. If an Option is an Incentive Stock Option, such
Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer. 
 (iii) Beneficiary Designation. Subject to the
approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, shall
thereafter be entitled to exercise the Option and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, the executor or administrator of the Participant’s estate shall be entitled to
exercise the Option and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation
would be inconsistent with the provisions of applicable laws. 
 (f) Vesting Generally. The total number of shares of Common Stock
subject to an Option may, but need not, vest and therefore become exercisable in periodic installments that may, but need not, be equal. The Option may be subject to such other terms and conditions on the time or times when it may be exercised
(which may be based on performance or other criteria) as the Board may deem appropriate. 

  
 9 








 
The vesting provisions of individual Options may vary. The provisions of this Section 6(f) are subject to any Option provisions governing the minimum number of shares of Common Stock as to
which an Option may be exercised. 
 (g) Termination of Continuous Service. Except as otherwise determined by the Board, in the event
that an Optionholder’s Continuous Service terminates (other than for Cause or upon the Optionholder’s death or Disability), the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such
Option as of the date of termination) but only within such period of time ending on the earlier of (i) the date three (3) months following the termination of the Optionholder’s Continuous Service (or such longer or shorter period
specified in the Option Agreement, which period shall not be less than 30 days unless such termination is for Cause) or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder
does not exercise his or her Option within the time specified in the Option Agreement, the Option shall terminate. 
 (h) Extension of
Termination Date. An Optionholder’s Option Agreement may also provide that if the exercise of the Option following the termination of the Optionholder’s Continuous Service (other than for Cause or upon the Optionholder’s death or
Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration of the
term of the Option set forth in Section 6(a) or (ii) the expiration of a period of three (3) months after the termination of the Optionholder’s Continuous Service during which the exercise of the Option would not be in violation
of such registration requirements. 
 (i) Disability of Optionholder. In the event that an Optionholder’s Continuous Service
terminates as a result of the Optionholder’s Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination), but only within such period of
time ending on the earlier of (i) the date 12 months following such termination (or such longer or shorter period specified in the Option Agreement, which period shall not be less than six (6) months) or (ii) the expiration of the
term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time specified herein, the Option shall terminate. 

(j) Death of Optionholder. Except as otherwise determined by the Board, in the event that (i) an Optionholder’s Continuous
Service terminates as a result of the Optionholder’s death or (ii) the Optionholder dies within the period (if any) specified in the Option Agreement after the termination of the Optionholder’s Continuous Service for a reason other
than death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder’s estate, by a person who acquired the right to exercise the Option by bequest or
inheritance or by a person designated to exercise the option upon the Optionholder’s death pursuant to Section 6(e), only within the period ending on the earlier of (i) the date 12 months following the date of death (or such longer or
shorter period specified in the Option Agreement, which period shall not be less than six (6) months) or (ii) the expiration of the term of such Option as set forth in the Option Agreement. If, after death, the Option is not exercised
within the relevant time period, the Option shall terminate. 
 (k) Termination for Cause. Except as otherwise determined by the
Board, in the event that Optionholder’s Continuous Service terminates as a result of the Optionholder being terminated for Cause, the Option shall terminate without any grace period, effective immediately as of the date and time of such
termination for Cause of the Optionholder, regardless of whether the Option is vested or unvested. 

  
 10 








 (l) Early Exercise. The Option may, but need not, include a provision whereby the
Optionholder may elect at any time before the Optionholder’s Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock subject to the Option prior to the full vesting of the Option. Subject to the
“Repurchase Limitation” in Section 10(f), any unvested shares of Common Stock so purchased may be subject to a repurchase option in favor of the Company or to any other restriction the Board determines to be appropriate. 

 

	7.	PROVISIONS OF AWARDS OTHER THAN OPTIONS. 


(a) Stock Bonus Awards. Each stock bonus agreement shall be in such form and shall contain such terms and conditions as the Board shall
deem appropriate. The terms and conditions of stock bonus agreements may change from time to time, and the terms and conditions of separate stock bonus agreements need not be identical. 

(i) Consideration. A stock bonus may be awarded in consideration for past services actually rendered to the Company or an Affiliate for
its benefit. 
 (ii) Vesting. Subject to the “Repurchase Limitation” in Section 10(f), shares of Common Stock awarded
under the stock bonus agreement may, but need not, be subject to a share repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

(iii) Termination of Participant’s Continuous Service. Subject to the “Repurchase Limitation” in Section 10(f), in
the event that a Participant’s Continuous Service terminates, the Company may reacquire any or all of the shares of Common Stock held by the Participant that have not vested as of the date of termination under the terms of the stock bonus
agreement. 
 (iv) Transferability. Rights to acquire shares of Common Stock under a stock bonus agreement shall be transferable only
to the extent set forth in the stock bonus agreement, or as the Board shall determine in its discretion. 
 (b) Restricted Stock
Awards. Each restricted stock agreement shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. The terms and conditions of the restricted stock agreements may change from time to time, and the
terms and conditions of separate restricted stock agreements need not be identical. 
 (i) Purchase Price. The purchase price of
Common Stock under a restricted stock award shall be determined by the Board. 
 (ii) Consideration. The purchase price of Common
Stock acquired pursuant to the restricted stock agreement shall be paid in cash at the time of purchase; provided, however, that the Board may permit payment, in its sole discretion, according to a deferred payment or other similar
arrangement with the Participant or in any other form of legal consideration that may be acceptable to the Board in its discretion and that is acceptable under applicable law (including performance of past services for the Company or an Affiliate);
provided, however, that at any time that the Company is incorporated in Delaware, then payment of the Common Stock’s “par value,” as defined in the Delaware General Corporation Law, shall not be made by deferred payment. 

  
 11 








 (iii) Vesting. Subject to the “Repurchase Limitation” in Section 10(f),
shares of Common Stock acquired under the restricted stock purchase agreement may, but need not, be subject to a share repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

(iv) Termination of Participant’s Continuous Service. Subject to the “Repurchase Limitation” in Section 10(f), in
the event that a Participant’s Continuous Service terminates, the Company may repurchase or otherwise reacquire any or all of the shares of Common Stock held by the Participant that have not vested as of the date of termination under the terms
of the restricted stock purchase agreement. 
 (v) Transferability. Rights to acquire shares of Common Stock under the restricted
stock agreement shall be transferable only to the extent set forth in the restricted stock agreement, or as the Board shall determine in its discretion. 

(c) Restricted Stock Unit Awards. Each restricted stock unit award agreement shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate. The terms and conditions of restricted stock unit award agreements may change from time to time, and the terms and conditions of separate restricted stock unit award agreements need not be identical.

 (i) Consideration. At the time of grant of a restricted stock unit award, the Board shall determine the consideration, if any, to
be paid by the Participant upon delivery of each share of Common Stock subject to the restricted stock unit award. To the extent required by applicable law, the consideration to be paid by the Participant for each share of Common Stock subject to a
restricted stock unit award shall not be less than the par value of a share of Common Stock. 
 (ii) Vesting. At the time of grant of
a restricted stock unit award, the Board shall impose such restrictions or conditions to the vesting of the restricted stock unit award as it, in its absolute discretion, deems appropriate. The Board may condition the vesting of the restricted stock
unit award upon the attainment of specified performance objectives established by the Board or such other factors as the Board may determine in its sole discretion, including time-based vesting. 

(iii) Payment. A restricted stock unit award shall be denominated in shares of Common Stock equivalents. A restricted stock unit award
shall be settled by the delivery of shares of Common Stock. 
 (iv) Termination of Participant’s Continuous Service. Except as
otherwise provided in the applicable restricted stock unit award agreement, such portion of the restricted stock unit award that has not vested shall be forfeited upon the Participant’s termination of Continuous Service for any reason. 

(v) Transferability. Restricted stock units shall be transferable by the Participant only upon such terms and conditions as are set
forth in the restricted stock unit agreement, or as the Board shall determine in its discretion. 
 (d) SARs. Each SAR agreement
shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. The terms and conditions of stock appreciation right agreements may change from time to time, and the terms and conditions of separate stock
appreciation right agreements need not be identical. 

  
 12 








 (i) Terms of SARs. The Board shall determine the terms of each SAR including, without
limitation: the number of shares subject to the SAR; the exercise price and the time or times during which the SAR may be settled; the consideration to be distributed on settlement of the SAR; and the effect of the Participant’s termination of
Continuous Service on each SAR. The exercise price of the SAR shall be determined by the Board when the SAR is granted, and may not be less than Fair Market Value. A SAR may be awarded upon satisfaction of Performance Factors, if any, during any
Performance Period as are set out in advance in the Participant’s individual Award Agreement. If the SAR is being earned upon the satisfaction of Performance Factors, then the Board shall: (i) determine the nature, length and starting date
of any Performance Period for each SAR and (ii) select from among the Performance Factors to be used to measure the performance, if any. Performance Periods may overlap and Participants may participate simultaneously with respect to SARs that
are subject to different Performance Factors and other criteria. 
 (ii) Exercise Period and Expiration Date. A SAR shall be
exercisable within the times or upon the occurrence of events determined by the Board and set forth in the Award Agreement governing such SAR. The SAR Agreement shall set forth the expiration date; provided that no SAR shall be exercisable
after the expiration of ten (10) years from the date the SAR is granted. The Board may also provide for SARs to become exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment
during a Performance Period of performance goals based on Performance Factors), in such number of shares or percentage of the shares of Common Stock subject to the SAR as the Committee determines. Except as may be set forth in the Participant’s
Award Agreement, vesting ceases on such Participant’s termination of Continuous Service (unless determined otherwise by the Board). 

(iii) Form of Settlement. Upon exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount
determined by multiplying the difference between the Fair Market Value of a share of Common Stock on the date of exercise over the exercise price times the number of shares with respect to which the SAR is exercised. At the discretion of the Board,
the payment from the Company for the SAR exercise may be in cash, in shares of equivalent value, or in some combination thereof. The portion of a SAR being settled may be paid currently or on a deferred basis with such interest or dividend
equivalent, if any, as the Board determines, provided that the terms of the SAR and any deferral satisfy the requirements of Section 409A of the Code. 

(v) Termination of Participant’s Continuous Service. Except as may be set forth in the Participant’s Award Agreement, vesting
ceases on such Participant’s termination of Continuous Service. 
 (vi) Transferability. SARs shall be transferable by the
Participant only upon such terms and conditions as are set forth in the stock appreciation rights agreement, or as the Board shall determine in its discretion. 

(e) Performance Awards. 

(i) General. A Performance Award is an award to a Participant of a cash bonus or a Performance Share bonus. Grants of Performance
Awards shall be made pursuant to an Award Agreement. 
 (ii) Terms of Performance Awards. The Board shall determine, and each Award
Agreement shall set forth, the terms of each award of Performance Award including, without limitation: 

  
 13 








 
the amount of any cash bonus; the number of shares of Common Stock deemed subject to a Performance Share bonus; the Performance Factors and Performance Period that shall determine the time and
extent to which each Performance Award shall be settled; the consideration to be distributed on settlement; and the effect of the Participant’s termination of Continuous Service on each Performance Award. In establishing Performance Factors and
the Performance Period the Board shall: (i) determine the nature, length and starting date of any Performance Period and (ii) select from among the Performance Factors to be used. Prior to settlement the Board shall determine the extent to
which Performance Awards have been earned. Performance Periods may overlap and Participants may participate simultaneously with respect to Performance Awards that are subject to different Performance Periods and different performance goals and other
criteria. No Participant shall be eligible to receive more than $3,000,000 in Performance Awards in any calendar year under this Plan. 

(iii) Value, Earning and Timing of Performance Shares. Any Performance Share bonus shall have an initial value equal to the Fair Market
Value of a share of Common Stock on the date of grant. After the applicable Performance Period has ended, the holder of a Performance Share bonus shall be entitled to receive a payout of the number of shares of Common Stock earned by the Participant
over the Performance Period, to be determined as a function of the extent to which the corresponding Performance Factors or other vesting provisions have been achieved. The Board, in its sole discretion, may pay an earned Performance Share bonus in
the form of cash, in shares of Common Stock (which have an aggregate Fair Market Value equal to the value of the earned Performance Shares at the close of the applicable Performance Period) or in a combination thereof. Performance Share bonuses may
also be settled in restricted stock. 
 (iv) Termination of Participant’s Continuous Service. Except as may be set forth in the
Participant’s Award Agreement, vesting ceases on such Participant’s termination of Continuous Service. 
 (f) Other Share-Based
Awards. Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof, may be granted either alone or in addition to other Awards provided under this Plan.
Subject to the provisions of the Plan, the Board shall have sole and complete authority to determine the persons to whom and the time or times such Other Share-Based Awards shall be granted, the number of shares of Common Stock (or the cash
equivalent thereof to be granted pursuant to such Other Share-Based Awards and all other terms and conditions of such Other Share-Based Awards. 
  

	8.	COVENANTS OF THE COMPANY. 


(a) Availability of Shares. During the terms of the Awards, the Company shall keep available at all times the number of shares of Common
Stock required to satisfy such Awards. 
 (b) Securities Law Compliance. The Company shall seek to obtain from each regulatory
commission or agency having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards. If, after reasonable efforts, the Company is unable to obtain from any
such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common
Stock upon exercise of such Awards unless and until such authority is obtained. 

  
 14 









	9.	USE OF PROCEEDS FROM STOCK. 


Proceeds from the sale of Common Stock pursuant to Awards shall constitute general funds of the Company. 

 

	10.	MISCELLANEOUS. 

 (a) Acceleration of Exercisability and Vesting.
The Board shall have the power to accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof shall vest in accordance with the Plan, notwithstanding the provisions in the Award stating the time
at which it may first be exercised or the time during which it shall vest. 
 (b) Stockholder Rights. No Participant shall be deemed
to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until such Participant has satisfied all requirements for exercise of the Award pursuant to its terms. 

(c) No Employment or other Service Rights. Nothing in the Plan or any instrument executed or Award granted pursuant thereto shall
confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or shall affect the right of the Company or an Affiliate to terminate (i) the employment of an
Employee with or without notice and with or without Cause, (ii) the service of a Consultant pursuant to the terms of such Consultant’s agreement with the Company or an Affiliate or (iii) the service of a Director pursuant to the
Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. 

(d) Incentive Stock Option $100,000 Limitation. To the extent that the aggregate Fair Market Value (determined at the time of grant) of
Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and its Affiliates) exceeds $100,000, the Options or portions thereof that
exceed such limit (according to the order in which they were granted) shall be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of an Award Agreement. 

(e) Withholding Obligations. Except as otherwise determined by the Board, it shall be a condition to the issuance of any Award and the
issuance of any shares of Common Stock in connection therewith that the Participant shall have paid over to the Company in cash the amount that the Company must withhold in order to satisfy any federal, state or local tax withholding obligation in
connection therewith. 
 (f) Repurchase Limitation. The terms of any repurchase option in favor of the Company shall be specified in
the Award. Except as otherwise determined by the Board, any repurchase option contained in an Award shall be upon the following terms: (i) if the repurchase option may give the Company the right to repurchase unvested shares of Common Stock
upon termination of Continuous Service, then such option shall be exercisable at the lower of: (1) the Fair Market Value per share on the date of repurchase; or (2) the original purchase price; and (ii) the option shall be
exercised (if at all) for cash or cancellation of purchase money indebtedness for the shares of Common Stock within 90 days of termination of Continuous Service (or in the case of shares of Common Stock issued upon exercise of Options after
such date of termination, within 90 days after the date of the exercise) or such longer period as may be agreed to by the Company and the Participant. 

  
 15 








 (g) Escrow. For purposes of facilitating the enforcement of the restrictions on a
Participant’s shares of Common Stock acquired pursuant to an Award as set forth in this Plan or in any Award Agreement, the Company may, at its discretion, require the holder of shares of Common Stock issued pursuant to such Award, to deliver
the certificate(s) for such shares with a stock power executed by him or her and by his or her spouse (if required for transfer), in blank, to the Secretary of the Company or his or her designee, to hold said certificate(s) and stock power(s) in
escrow and to take all such actions and to effectuate all such transfers and/or releases as are in accordance with the terms of this Plan or the Award Agreement. The certificates may be held in escrow so long as such shares whose ownership they
evidence are subject to any right of repurchase or other restriction under this Plan or under an Award Agreement, and shall be released by the escrow holder to the record owner of such shares (or to any permitted transferee of such owner) when they
are no longer subject to any right of repurchase or first refusal under this Plan or under the Award Agreement. Each Participant, by executing an Award Agreement, thereby acknowledges that the Secretary of the Company (or his or her designee) is so
appointed as the escrow holder with the foregoing authorities as a material inducement to the grant of an Award under this Plan, that the appointment is coupled with an interest, and that it accordingly shall be irrevocable. The escrow holder shall
not be liable to any party to the Award Agreement (or to any other party) for any actions or omissions unless the escrow holder is grossly negligent relative thereto. The escrow holder may rely upon any letter, notice or other document executed by
any signature purported to be genuine. 
 (h) Compliance with Section 409A. Unless otherwise expressly provided for in an Award
Agreement, the Plan and Award Agreements shall be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance
with Section 409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award shall incorporate the terms and
conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award
Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes
“deferred compensation” under Section 409A of the Code is a “specified employee” for purposes of Section 409A of the Code, no distribution or payment of any amount that is due because of a “separation from
service” (as defined in Section 409A of the Code without regard to alternative definitions thereunder) shall be issued or paid before the date that is six (6) months following the date of such Participant’s “separation from
service” or, if earlier, the date of the Participant’s death, unless such distribution or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred shall be paid in a lump sum on the day
after such six (6) month period elapses, with the balance paid thereafter on the original schedule. 
 (i) Clawback/Recovery.
All Awards granted under the Plan shall be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the
Company’s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provision in an
Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. 

  
 16 








 (j) Electronic Delivery. Any reference herein to a “written” agreement or
document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company’s intranet (or other shared electronic medium controlled by the Company
to which the Participant has access). 
 (k) Deferrals. To the extent permitted by applicable law, the Board, in its sole discretion,
may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by
Participants. Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise
providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant’s termination
of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. 
  

	11.	ADJUSTMENTS UPON CHANGES IN STOCK. 


(a) Capitalization Adjustments. If any change is made in, or other event occurs with respect to, the Common Stock subject to the Plan or
subject to any Award without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend,
combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company (each a “Capitalization Adjustment”)), the Plan shall be appropriately
adjusted in the class(es) and maximum number of securities subject to the Plan pursuant to the outstanding Awards shall be appropriately adjusted in the class(es) and number of securities and price per share of Common Stock subject to such
outstanding Awards. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. (The conversion of any convertible securities of the Company shall not be treated as a transaction “without receipt of
consideration” by the Company.) 
 (b) Dissolution or Liquidation. In the event of a dissolution or liquidation of the Company,
then all outstanding Options shall terminate immediately prior to the completion of such dissolution or liquidation, and shares of Common Stock subject to any Company repurchase option may, in the sole discretion of the Company, be repurchased by
the Company notwithstanding the fact that the holder of such stock is then in Continuous Service. 
 (c) Corporate Transaction. In
the event of a Corporate Transaction, any surviving corporation or acquiring corporation may assume or continue any or all Awards outstanding under the Plan or may substitute similar awards for Awards outstanding under the Plan (it being understood
that similar awards include, but are not limited to, awards to acquire the same consideration paid to the stockholders or the Company, as the case may be, pursuant to the Corporate Transaction), and any reacquisition or repurchase rights held by the
Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or such successor’s parent company), if any, in connection with such Corporate Transaction. In the event that any
surviving corporation or acquiring corporation does not assume or continue any or all such outstanding Awards or substitute similar Awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted
and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Corporate Transaction, the vesting of such Awards (and, if 

  
 17 








 
applicable, the time at which such Awards may be exercised) shall be accelerated in full (contingent upon the effectiveness of the Corporate Transaction) to the date that is five (5) days
prior to the effective time of the Corporate Transaction), the Awards shall terminate if not exercised (if applicable) at or prior to such effective time, and any reacquisition or repurchase rights held by the Company with respect to such Awards
held by Participants whose Continuous Service has not terminated shall (contingent upon the effectiveness of the Corporate Transaction) lapse. Otherwise, with respect to any Awards outstanding under the Plan that have not been assumed, continued or
substituted, the vesting of such Awards (and, if applicable, the time at which such Award may be exercised) shall not be accelerated, unless otherwise provided in a written agreement between the Company or any Affiliate and the holder of such Award,
and such Awards shall terminate if not exercised (if applicable) prior to the effective time of the Corporate Transaction. 
 (d) Change
in Control. An Award may be subject to additional acceleration of vesting and exercisability upon or after a Corporate Transaction as may be provided in the agreement for such Award or as may be provided in any other written agreement between
the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur, except as otherwise set forth above. 
  

	12.	AMENDMENT OF THE PLAN AND AWARDS. 


(a) Amendment of Plan. The Board at any time, and from time to time, may amend the Plan. However, except as provided in
Section 11(a) relating to Capitalization Adjustments, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary to satisfy the requirements of Section 422 of the Code
or of the listing standards of any national securities exchange or association on which the Company’s securities are listed. 
 (b)
Stockholder Approval. The Board, in its sole discretion, may submit any other amendment to the Plan for stockholder approval. 
 (c)
Contemplated Amendments. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible Employees with the maximum benefits provided or to be provided under the provisions
of the Code and the regulations promulgated thereunder relating to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or bringing the Plan or Awards granted under the Plan into compliance
with the requirements for Incentive Stock Options or ensuring that they are exempt from, or compliant with, the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of
applicable law. 
 (d) No Impairment of Rights. Rights under any Award granted before amendment of the Plan shall not be impaired by
any amendment of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing. 

(e) Amendment of Awards. The Board at any time, and from time to time, may amend the terms of any one or more Awards; provided,
however, that the rights under any Award shall not be impaired by any such amendment unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing. 

  
 18 









	13.	TERMINATION OR SUSPENSION OF THE PLAN. 


(a) Plan Term. The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate on the day
before the 10th anniversary of the date the Plan is adopted by the Board or approved by the stockholders of the Company, whichever is earlier. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. 

(b) No Impairment of Rights. Suspension or termination of the Plan shall not impair rights and obligations under any Award granted
while the Plan is in effect except with the written consent of the Participant. 
  

	14.	EFFECTIVE DATE OF PLAN. 

 The
Plan shall become effective on the IPO Date; provided, however, that it has been adopted by the Board prior to such date; provided further that no Award shall be exercised (or, in the case of any Award other than an Option, shall be
granted) unless and until the Plan has been approved by the stockholders of the Company, which approval shall be within 12 months before or after the date the Plan is adopted by the Board. “IPO Date” means the date of the
underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering. 

 

	15.	CHOICE OF LAW. 

 The law of the State of
California shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such state’s conflict of laws rules. 

  
 19 








 TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

STOCK OPTION GRANT NOTICE 

TRIVASCULAR TECHNOLOGIES, INC. (the “Company”),
pursuant to its 2014 Equity Incentive Plan (the “Plan”), hereby grants to Optionholder an option to purchase the number of shares of the Company’s Common Stock set forth below. The option evidenced hereby (the
“Option”) is subject to all of the terms and conditions as set forth herein and in the Stock Option Agreement, the Plan and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety.
Capitalized terms not otherwise defined herein will have the meanings set forth in the Plan. 
  

					
	Optionholder:	  	  

	Date of Grant:	  	  

	Vesting Commencement Date:	  	  

	Number of Shares Subject to Option:	  	  

	Exercise Price (Per Share):	  	  

	Total Exercise Price:	  	  

	Expiration Date:	  	  

			
	Type of Grant:	  	  ̈ Incentive Stock Option
	  	 ̈ Nonstatutory Stock Option

 Notwithstanding any designation set forth above as an Incentive Stock Option, the Option will only be an Incentive Stock
Option to the extent so qualifying under applicable tax laws; to the extent not so qualifying, the Option will be a Nonstatutory Stock Option.1 

 

			
	Vesting Schedule:	  	This Option shall vest and become exercisable with respect to 1/4th of the underlying shares (or              shares) 12 months after the Vesting Commencement Date. On the
first day of each calendar month thereafter, the option shall vest and become exercisable with respect to 1/48th of the underlying shares (or              shares), until the option is fully
vested. Notwithstanding the foregoing, vesting will cease upon the Optionholder’s termination of Continuous Service (as defined in the Plan).
		
	Payment:	  	 By one or a combination of the following marked items (described in the Stock Option Agreement):

 
  ̈ By cash or check

 
  ̈ Pursuant to a Regulation T Program if
the Shares are publicly traded
  
  ̈ By
delivery of already-owned shares if the Shares are publicly traded
  
  ̈ By “net exercise”


  

	1 	If this is an incentive stock option, it (plus your other outstanding incentive stock options) cannot be first exercisable for more than $100,000 in any calendar year. Any excess over $100,000 is a
nonstatutory stock option. 








 Additional Terms/Acknowledgements: The undersigned Optionholder acknowledges receipt of,
and understands and agrees to, this Grant Notice, the Stock Option Agreement and the Plan, and makes each of the representations required to be made by Optionholder thereunder. Optionholder acknowledges that the Company has given no legal or tax
advice concerning the options and has advised Optionholder to consult with Optionholder’s own tax or financial advisor about the tax treatment of the option and its exercise. Optionholder further acknowledges that as of the Date of Grant, this
Grant Notice, the Stock Option Agreement and the Plan set forth the entire understanding between Optionholder and the Company regarding the acquisition of stock in the Company and supersede all prior oral and written agreements on that subject with
the exception of: (i) options previously granted and delivered to Optionholder under the Plan or the Company’s other equity incentive plans; and (ii) the following agreements only: 

 

			
	Other Agreements (if any):	 	  

	  

	  


  

									
	TRIVASCULAR TECHNOLOGIES, INC.	 		 	OPTIONHOLDER:
				
	By:	 	  
	 		 	  

		 	Signature	 		 	Signature
					
	Title:	 	  
	 		 	Date:	 	  

					
	Date:	 	  
	 		 		 	

 ATTACHMENTS: Stock Option Agreement, 2014 Equity Incentive Plan and Notice of Exercise.








 ATTACHMENT I 

TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

STOCK OPTION AGREEMENT 

Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement,
TRIVASCULAR TECHNOLOGIES, INC. (the “Company”) has granted you an option under its 2014 Equity Incentive Plan (the “Plan”) to purchase
the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the
same definitions as in the Plan. 
 The details of your option are as follows: 

1. VESTING. Subject to the limitations contained herein, your option will vest as provided in your Grant Notice,
provided that vesting will cease upon the termination of your Continuous Service. 
 2. NUMBER OF
SHARES AND EXERCISE PRICE. The number of shares of Common Stock subject to your option and your exercise price per share referenced in your Grant Notice may be adjusted from time to
time for Capitalization Adjustments. 
 3. ISO EXERCISE LIMITATION. The aggregate Fair Market Value of
the shares of Common Stock with respect to which you may exercise your option for the first time during any calendar year, when added to the aggregate Fair Market Value of the shares of Common Stock subject to any other options designated as
Incentive Stock Options and granted to you under any stock option plan of the Company or an Affiliate prior to the Date of Grant with respect to which such options are exercisable for the first time during the same calendar year, shall not exceed
$100,000 (the “ISO Exercise Limitation”) unless applicable law requires that your option be exercisable sooner. For purposes of this Section 3, your options designated as Incentive Stock Options shall be taken into
account in the order in which they were granted to you, and the Fair Market Value of shares of Common Stock shall be determined as of the time the option with respect to such shares of Common Stock is granted. If Section 422 of the Code is
amended to provide for a different limitation from that set forth in this provision, the ISO Exercise Limitation shall be deemed amended effective as of the date required or permitted by such amendment to the Code. 

4. METHOD OF PAYMENT. Payment of the exercise price, and any required payment associated
with the Company’s withholding obligations as set forth in the Plan and Section 11 below, are due in full upon exercise of all or any part of your option. You may elect to make payment of the exercise price in cash or by check or in any
other manner permitted by your Grant Notice, which may include one or more of the following: 
 (a) In the
Company’s sole discretion at the time your option is exercised and provided that at the time of exercise the Common Stock is publicly traded and quoted regularly in The Wall Street Journal, pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Stock, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to
the Company from the sales proceeds (this manner of payment is also known as a “broker-assisted exercise”, “same day sale”, or “sell to cover”); or 







 (b) Provided that at the time of exercise the Common Stock is publicly traded, by
delivery to the Company (either by actual delivery or attestation) of already-owned shares of Common Stock that are owned free and clear of any liens, claims, encumbrances or security interests, and that are valued at Fair Market Value on the date
of exercise. “Delivery” for these purposes, in the sole discretion of the Company at the time you exercise your option, will include delivery to the Company of your attestation of ownership of such shares of Common Stock in a
form approved by the Company. You may not exercise your option by delivery to the Company of Common Stock if doing so would violate the provisions of any law, regulation or agreement restricting the redemption of the Company’s stock. 

(c) If this option is a Nonstatutory Stock Option, subject to the consent of the Company at the time of exercise, by a “net
exercise” arrangement pursuant to which the Company will reduce the number of shares of Common Stock issued upon exercise of your option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise
price. You must pay any remaining balance of the aggregate exercise price not satisfied by the “net exercise” in cash or other permitted form of payment. Shares of Common Stock will no longer be outstanding under your option and will not
be exercisable thereafter if those shares (i) are used to pay the exercise price pursuant to the “net exercise,” (ii) are delivered to you as a result of such exercise, and (iii) are withheld to satisfy your tax withholding
obligations. 
 5. WHOLE SHARES. You may exercise your option only for whole shares of Common Stock.

 6. SECURITIES LAW COMPLIANCE. Notwithstanding anything to the contrary contained
herein, you may not exercise your option unless the shares of Common Stock issuable upon such exercise are then registered under the Securities Act or, if such shares of Common Stock are not then so registered, the Company has determined that such
exercise and issuance would be exempt from the registration requirements of the Securities Act. The exercise of your option also must comply with other applicable laws and regulations governing your option, and you may not exercise your option if
the Company determines that such exercise would not be in material compliance with such laws and regulations. 
 7.
TERM. You may not exercise your option before the commencement of its term or after its term expires. The term of your option commences on the Date of Grant and expires as provided in the Plan, or upon the earliest of the
following: 
 (a) immediately upon the termination of your Continuous Service for Cause; 

(b) three (3) months after the termination of your Continuous Service for any reason other than Cause, Disability or death,
provided that if during any part of such 3-month period you may not exercise your option solely because of the condition set forth in the preceding paragraph relating to “Securities Law Compliance,” your option shall not expire until the
earlier of the Expiration Date or until it shall have been exercisable for an aggregate period of 3 months after the termination of your Continuous Service; 

(c) twelve (12) months after the termination of your Continuous Service due to your Disability; 

(d) twelve (12) months after your death if you die either during your Continuous Service or within three (3) months after
your Continuous Service terminates for any reason other than Cause; 







 (e) the Expiration Date indicated in your Grant Notice; 

(f) the day before the 10th anniversary of the Date of Grant. 

If your option is an Incentive Stock Option, note that, to obtain the federal income tax advantages associated with an Incentive Stock Option,
the Code requires that at all times beginning on the date of grant of your option and ending on the day three (3) months before the date of your option’s exercise, you must be an employee of the Company or an Affiliate, except in the event
of your death or Disability. To the extent that the Company has provided, or provides in the future, for extended exercisability of your option under certain circumstances for your benefit, the Company cannot guarantee that your option will
necessarily be treated as an Incentive Stock Option. 
 8. EXERCISE. 

(a) You may exercise the vested portion of your option during its term by delivering a Notice of Exercise (in a form designated by the
Company) together with the exercise price to the Secretary of the Company, or to such other person as the Company may designate, during regular business hours, together with such additional documents as the Company may then require. 

(b) As a condition to any exercise of your option, you also agree that you must make arrangements to deliver to the Company the amount
of any tax withholding obligation of the Company arising by reason of: (i) the exercise of your option; (ii) the lapse of any substantial risk of forfeiture to which the shares of Common Stock are subject at the time of exercise; or
(iii) the disposition of shares of Common Stock acquired upon such exercise. 
 (c) If your option is an Incentive Stock
Option, by exercising your option you agree that you will notify the Company in writing within 15 days after the date of any disposition of any of the shares of the Common Stock issued upon exercise of your option that occurs within two
(2) years after the date of your option grant or within one (1) year after such shares of Common Stock are transferred upon exercise of your option. 

(d) By exercising your option you agree (in addition to any restrictions on transfer under any applicable securities laws) that you
shall not sell, dispose of, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, any shares of Common Stock or other securities of the
Company held by you, for a period of time specified by the managing underwriter(s) in any public offering of securities of the Company (not to exceed 180 days or such longer period as may be necessary to allow any managing underwriter to comply with
FINRA rules (the “Lock Up Period”)). You further agree to execute and deliver such other agreements as may be reasonably requested by the Company and/or the underwriter(s) that are consistent with the foregoing or that are
necessary to give further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to your shares of Common Stock until the end of such period. The underwriters of the Company’s
stock are intended third party beneficiaries of this Section 8(d) and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 

9. TRANSFERABILITY. 

(a) If your option is an Incentive Stock Option, your option is not transferable, except by will or by the laws of descent and
distribution and is exercisable during your life only by you. Notwithstanding the foregoing, by delivering written notice to the Company, in a form satisfactory to the Company, you may designate a third party who, in the event of your death, shall
thereafter be entitled to exercise your option. 







 (b) If your option is a Nonstatutory Stock Option, your option is not transferable,
except: (i) by will or by the laws of descent and distribution; (ii) with the prior written approval of the Company, by instrument to an inter vivos or testamentary trust, in a form accepted by the Company, in which the option is to be
passed to beneficiaries upon the death of the trustor (settlor); or (iii) with the prior written approval of the Company, by gift, in a form accepted by the Company, to a permitted transferee under applicable securities laws. 

10. OPTION NOT A SERVICE CONTRACT. Your option is not an
employment or service contract, and nothing in your option shall be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company or an Affiliate, or of the Company or an Affiliate to continue your
employment. In addition, nothing in your option shall obligate the Company or an Affiliate, their respective stockholders, Boards of Directors, Officers or Employees to continue any relationship that you might have as a Director or Consultant for
the Company or an Affiliate. 
 11. WITHHOLDING OBLIGATIONS. 

(a) At the time you exercise your option, in whole or in part, or at any time thereafter as requested by the Company, you hereby
authorize withholding from payroll and any other amounts payable to you, and otherwise agree to pay over to the Company in cash (or make other adequate provision for as approved by the Company in its sole discretion, including by means of a
“same day sale” pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company) any sums required to satisfy the federal, state, local and foreign tax withholding
obligations of the Company or an Affiliate, if any, which arise in connection with the exercise of your option. 
 (b) If this
option is a Nonstatutory Stock Option, then upon your request and subject to approval by the Company, and compliance with any applicable legal conditions or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise
issuable to you upon the exercise of your option a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date of exercise, not in excess of the minimum amount of tax required to be withheld by law (or
such lower amount as may be necessary to avoid classification of your option as a liability for financial accounting purposes). If the date of determination of any tax withholding obligation is deferred to a date later than the date of exercise of
your option, share withholding pursuant to the preceding sentence shall not be permitted unless you make a proper and timely election under Section 83(b) of the Code, covering the aggregate number of shares of Common Stock acquired upon such
exercise with respect to which such determination is otherwise deferred, to accelerate the determination of such tax withholding obligation to the date of exercise of your option. Notwithstanding the filing of such election, shares of Common Stock
shall be withheld solely from fully vested shares of Common Stock determined as of the date of exercise of your option that are otherwise issuable to you upon such exercise. Any adverse consequences to you arising in connection with such share
withholding procedure shall be your sole responsibility. 
 (c) You may not exercise your option unless the tax withholding
obligations of the Company and/or any Affiliate are satisfied. Accordingly, you may not be able to exercise your option when desired even though your option is vested, and the Company shall have no obligation to issue a certificate for such shares
of Common Stock or release such shares of Common Stock from any escrow provided for herein unless such obligations are satisfied. 







 12. TAX CONSEQUENCES. You hereby agree that the Company does
not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes your tax liabilities. You will not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related
to tax liabilities arising from your option or your other compensation. In particular, you acknowledge that this option is exempt from Section 409A of the Code only if the exercise price per share specified in the Grant Notice is at least equal
to the “fair market value” per share of the Common Stock on the Date of Grant and there is no other impermissible deferral of compensation associated with the option. 

13. EFFECT ON OTHER EMPLOYEE BENEFIT PLANS.
The value of this option will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan
otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company’s or any Affiliate’s employee benefit plans. 

14. NOTICES. Any notices provided for in your option or the Plan will be given in writing (including electronically) and
will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the
Company. The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this option by electronic means or to request your consent to participate in the Plan by electronic means. By accepting this
option, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. 

15. GOVERNING PLAN DOCUMENT. Your option is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of your option, and is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict
between the provisions of your Option and those of the Plan, the provisions of the Plan shall control. 
 16. OTHER
DOCUMENTS. You hereby acknowledge receipt of and the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus. In addition, you
acknowledge receipt of the Company’s Insider Trading Policy and Code of Conduct and Ethics, as in effect from time to time. 

17. VOTING RIGHTS. You will not have voting or any other rights as a stockholder of the Company with
respect to the shares to be issued pursuant to this option until such shares are issued to you. Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company. Nothing contained in this option, and no action taken
pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person. 

18. SEVERABILITY. If all or any part of this Stock Option Agreement or the Plan is declared by any court or governmental
authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Stock Option Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Stock Option Agreement (or part of such a
Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid. 







 19. MISCELLANEOUS.  

(a) The rights and obligations of the Company under your Option shall be transferable by the Company to any one or more persons or
entities, and all covenants and agreements hereunder shall inure to the benefit of, and be enforceable by, the Company’s successors and assigns. 

(b) You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the
Company to carry out the purposes or intent of your Option. 
 (c) You acknowledge and agree that you have reviewed your Option in
its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Option and fully understand all provisions of your Option. 

(d) This Stock Option Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any
governmental agencies or national securities exchanges as may be required. 
 (e) All obligations of the Company under the Plan and
this Stock Option Agreement shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business
and/or assets of the Company. 
 ***** 

This Stock Option Agreement will be deemed to be signed by you upon the signing by you of the Stock Option Grant Notice to which it is
attached. 







 ATTACHMENT II 

2014 Equity Incentive Plan 







 ATTACHMENT III 

TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

NOTICE OF EXERCISE 
 TriVascular
Technologies, Inc. 
 3910 Brickway Blvd. 
 Santa Rosa, CA 95403

 ATTN: President 
 Date of Exercise:
                     
 Ladies and Gentlemen: 

This constitutes notice under my stock option that I elect to purchase the number of shares for the price set forth below. 

 

					
	 Type of option:
	  			
		  	  
	  
	 
		
	 Stock option dated:
	  			
		  	  
	  
	 
		
	 Number of shares as to which option is exercised:
	  			
		  	  
	  
	 
		
	 Certificates to be issued in name of:
	  			
		  	  
	  
	 
		
	 Total exercise price:
	  	$	            	  
		  	  
	  
	 
		
	 [Cash][Other] payment delivered herewith:
	  	$	            	  
		  	  
	  
	 

 By this exercise, I agree: (i) to provide such additional documents as you may require pursuant to the
terms of the 2014 Equity Incentive Plan; (ii) to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option; and (iii) if this exercise relates to
an incentive stock option, to notify you in writing within 15 days after the date of any disposition of any of the shares of Common Stock issued upon exercise of this option that occurs within two years after the date of grant of this option or
within one year after such shares of Common Stock are issued upon exercise of this option. 
  

	
	Very truly yours,
	
	  

	Name:









 TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

RESTRICTED STOCK UNIT GRANT NOTICE 

TRIVASCULAR TECHNOLOGIES, INC. (the “Company”),
pursuant to its 2014 Equity Incentive Plan (the “Plan”), hereby awards to Participant a restricted stock unit award for the number of shares of the Company’s Common Stock (“Restricted Stock
Units”) set forth below (the “Award”). The Award is subject to all of the terms and conditions as set forth in this notice of grant (this “Restricted Stock Unit Grant Notice”), the
Restricted Stock Unit Award Agreement (the “Award Agreement”) and the Plan, both of which are attached hereto and incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meanings
set forth in the Plan or the Award Agreement. In the event of any conflict between the terms in the Award and the Plan, the terms of the Plan shall control. 
  

					
	Participant:	  	  

	Date of Grant:	  	  

	Vesting Commencement Date:	  	  

	 Number of Restricted Stock Units/Shares:
	  	  

	 ID or Grant Number:
	  	  


  

			
	Vesting Schedule:	  	 The shares subject to the Award shall vest as follows:

                          
                                         
                                         
                                         
                   .

		
	Issuance Schedule:	  	Subject to any change on a Capitalization Adjustment, one share of Common Stock will be issued for each Restricted Stock Unit that vests at the time set forth in Section 6 of the Award Agreement.:

 Additional Terms/Acknowledgements: Participant acknowledges receipt of, and understands and agrees to, this Restricted
Stock Unit Grant Notice, the Award Agreement and the Plan. Participant further acknowledges that as of the Date of Grant, this Restricted Stock Unit Grant Notice, the Award Agreement and the Plan set forth the entire understanding between
Participant and the Company regarding the acquisition of the Common Stock pursuant to the Award specified above and supersede all prior oral and written agreements on the terms of this Award with the exception, if applicable, of (i) the written
employment agreement or offer letter agreement entered into between the Company and Participant specifying the terms that should govern this specific Award, and (ii) any compensation recovery policy that is adopted by the Company or is
otherwise required by applicable law. 
 By accepting this Award, Participant acknowledges having received and read the Restricted Stock Unit Grant Notice,
the Award Agreement and the Plan and agrees to all of the terms and conditions set forth in these documents. Participant consents to receive Plan documents by electronic delivery and to participate in the Plan through an on-line or electronic system
established and maintained by the Company or another third party designated by the Company. 
  

			
	Other Agreements (if any):	 	  

	  

	  










									
	TRIVASCULAR TECHNOLOGIES, INC.	 		 	PARTICIPANT:
				
	By:	 	  
	 		 	  

		 	Signature	 		 	Signature
					
	Title:	 	  
	 		 	Date:	 	  

					
	Date:	 	  
	 		 		 	

 ATTACHMENTS: Award Agreement and 2014 Equity Incentive Plan. 







 ATTACHMENT I 

TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

RESTRICTED STOCK UNIT AWARD AGREEMENT 

Pursuant to your Restricted Stock Unit Grant Notice (“Grant Notice”) and this Restricted Stock Unit Award Agreement
(the “Agreement”), TRIVASCULAR TECHNOLOGIES, INC. (the “Company”) has awarded you (“Participant”) a Restricted
Stock Unit Award (the “Award”) under its 2014 Equity Incentive Plan (the “Plan”) for the number of Restricted Stock Units/shares indicated in your Grant Notice. Defined terms not explicitly defined in
this Agreement or the Grant Notice shall have the same definitions as in the Plan. The terms of your Award, in addition to those set forth in the Grant Notice, are as follows. 

The details of your Award are as follows: 

1. GRANT OF THE AWARD. This Award represents the right to be issued on a
future date one (1) share of Common Stock for each Restricted Stock Unit that vests on the applicable vesting date(s) (subject to any adjustment under Section 3 below) as indicated in the Grant Notice. As of the Date of Grant, the Company
will credit to a bookkeeping account maintained by the Company for your benefit (the “Account”) the number of Restricted Stock Units/shares of Common Stock subject to the Award. This Award was granted in consideration of your
services to the Company. 
 2. VESTING. Subject to the limitations contained herein, your Award will vest, if at all,
in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service. Upon such termination of your Continuous Service, the Restricted Stock Units/shares of Common
Stock credited to the Account that were not vested on the date of such termination will be forfeited at no cost to the Company and you will have no further right, title or interest in or to such underlying shares of Common Stock. 

3. NUMBER OF SHARES. The number of Restricted Stock Units/shares subject to your Award may
be adjusted from time to time for Capitalization Adjustments, as provided in the Plan. Any additional Restricted Stock Units, shares, cash or other property that becomes subject to the Award pursuant to this Section 3, if any, shall be subject,
in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable to the other Restricted Stock Units and shares covered by your Award. Notwithstanding the
provisions of this Section 3, no fractional shares or rights for fractional shares of Common Stock shall be created pursuant to this Section 3. Any fraction of a share will be rounded down to the nearest whole share. 

4. SECURITIES LAW COMPLIANCE. You may not be issued any Common Stock under your Award
unless the shares of Common Stock underlying the Restricted Stock Units are either (i) then registered under the Securities Act, or (ii) the Company has determined that such issuance would be exempt from the registration requirements of
the Securities Act. Your Award must also comply with other applicable laws and regulations governing the Award, and you shall not receive such Common Stock if the Company determines that such receipt would not be in material compliance with such
laws and regulations. 
 5. TRANSFER RESTRICTIONS. Prior to the time that shares of Common Stock have
been delivered to you, you may not transfer, pledge, sell or otherwise dispose of this Award or the shares issuable in respect of your Award, except as expressly provided in this Section 5. For example, you may not use shares that may be issued
in respect of your Restricted Stock Units as security for a loan. The restrictions on transfer set forth herein will lapse upon delivery to you of shares in respect of your vested Restricted Stock Units. 







 (a) Death. Your Award is transferable by will and by the laws of descent and distribution.
At your death, vesting of your Award will cease and your executor or administrator of your estate shall be entitled to receive, on behalf of your estate, any Common Stock or other consideration that vested but was not issued before your death. 

(b) Domestic Relations Orders. Upon receiving written permission from the Board or its duly authorized designee, and provided that you
and the designated transferee enter into transfer and other agreements required by the Company, you may transfer your right to receive the distribution of Common Stock or other consideration hereunder, pursuant to a domestic relations order or
marital settlement agreement that contains the information required by the Company to effectuate the transfer. You are encouraged to discuss the proposed terms of any division of this Award with the Company General Counsel prior to finalizing the
domestic relations order or marital settlement agreement to verify that you may make such transfer, and if so, to help ensure the required information is contained within the domestic relations order or marital settlement agreement. 

6. DATE OF ISSUANCE. The issuance of shares in respect of the Restricted Stock Units is
intended to comply with Treasury Regulations Section 1.409A-1(b)(4) and will be construed and administered in such a manner. Subject to the satisfaction of the withholding obligations set forth in this Agreement, in the event one or more
Restricted Stock Units vests, the Company shall issue to you one (1) share of Common Stock for each Restricted Stock Unit that vests on the applicable vesting date(s) (subject to any adjustment under Section 3 above). The issuance date
determined by this paragraph is referred to as the “Original Issuance Date”. 
 If the Original Issuance Date falls on a date that
is not a business day, delivery shall instead occur on the next following business day. In addition, if 
 (a) the Original Issuance
Date does not occur (1) during an “open window period” applicable to you, as determined by the Company in accordance with the Company’s then-effective policy on trading in Company securities, or (2) on a date when you are
otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market, and 
 (b) either
(1) Withholding Taxes do not apply, or (2) the Company decides, prior to the Original Issuance Date, (A) not to satisfy the Withholding Taxes by withholding shares of Common Stock from the shares otherwise due, on the Original
Issuance Date, to you under this Award, and (B) not to permit you to pay your Withholding Taxes in cash, 
 then the shares that would otherwise
be issued to you on the Original Issuance Date will not be delivered on such Original Issuance Date and will instead be delivered on the first business day when you are not prohibited from selling shares of the Company’s Common Stock in the
open public market, but in no event later than December 31 of the calendar year in which the Original Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance Date occurs), or, if and only if
permitted in a manner that complies with Treasury Regulations Section 1.409A-1(b)(4), no later than the date that is the 15th day of the third calendar month of the applicable year following the year in which the shares of Common Stock under
this Award are no longer subject to a “substantial risk of forfeiture” within the meaning of Treasury Regulations Section 1.409A-1(d). 
 The
form of delivery (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company. 

  
 2 








 7. RESTRICTIVE LEGENDS. The shares of Common Stock issued
under your Award shall be endorsed with appropriate legends as determined by the Company. 
 8. DIVIDENDS. You shall
receive no benefit or adjustment to your Award with respect to any cash dividend, stock dividend or other distribution that does not result from a Capitalization Adjustment. 

9. EXECUTION OF DOCUMENTS. You hereby acknowledge and agree that the manner selected by
the Company by which you indicate your consent to your Grant Notice is also deemed to be your execution of your Grant Notice and of this Agreement. You further agree that such manner of indicating consent may be relied upon as your signature for
establishing your execution of any documents to be executed in the future in connection with your Award. 
 10. AWARD
NOT A SERVICE CONTRACT. Nothing in this Agreement (including, but not limited to, the vesting of your Award or the issuance of the shares subject to your Award), the Plan or any
covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan shall: (i) confer upon you any right to continue in the employ of, or affiliation with, the Company or an Affiliate; (ii) constitute any
promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or affiliation; (iii) confer any right or benefit
under this Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this Agreement or Plan; or (iv) deprive the Company of the right to terminate you at will and without regard to any future vesting
opportunity that you may have. 
 The Company has the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or
Affiliates at any time or from time to time, as it deems appropriate (a “reorganization”). Such a reorganization could result in the termination of your Continuous Service, or the termination of Affiliate status of your
employer and the loss of benefits available to you under this Agreement, including but not limited to, the termination of the right to continue vesting in the Award. This Agreement, the Plan, the transactions contemplated hereunder and the vesting
schedule set forth herein or any covenant of good faith and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement as an employee or consultant for the term of this Agreement,
for any period, or at all, and shall not interfere in any way with the Company’s right to conduct a reorganization. 
 11.
WITHHOLDING OBLIGATIONS. 
 (a) On each vesting date, and on or before the time you receive a
distribution of the shares underlying your Restricted Stock Units, and at any other time as reasonably requested by the Company in accordance with applicable tax laws, you hereby authorize any required withholding from the Common Stock issuable to
you and/or otherwise agree to make adequate provision in cash for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or any Affiliate that arise in connection with your Award (the
“Withholding Taxes”). Additionally, the Company or any Affiliate may, in its sole discretion, satisfy all or any portion of the Withholding Taxes obligation relating to your Award by any of the following means or by a
combination of such means: (i) withholding from any compensation otherwise payable to you by the Company; (ii) causing you to tender a cash payment; (iii) permitting or requiring you to enter into a “same day sale”
commitment, if applicable, with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby you irrevocably elect to sell a portion of the shares to be delivered in connection
with your Restricted Stock Units to satisfy the Withholding Taxes and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Withholding Taxes directly to the Company and/or its Affiliates; or
(iv) withholding shares of Common Stock from the shares of 

  
 3 








 
Common Stock issued or otherwise issuable to you in connection with the Award with a Fair Market Value (measured as of the date shares of Common Stock are issued to pursuant to Section 6)
equal to the amount of such Withholding Taxes; provided, however, that the number of such shares of Common Stock so withheld will not exceed the amount necessary to satisfy the Company’s required tax withholding obligations using the
minimum statutory withholding rates for federal, state, local and foreign tax purposes, including payroll taxes, that are applicable to supplemental taxable income; and provided, further, that to the extent necessary to qualify for an
exemption from application of Section 16(b) of the Exchange Act, if applicable, such share withholding procedure will be subject to the express prior approval of the Company’s Compensation Committee. 

(b) Unless the tax withholding obligations of the Company and/or any Affiliate are satisfied, the Company shall have no obligation to
deliver to you any Common Stock. 
 (c) In the event the Company’s obligation to withhold arises prior to the delivery to you of
Common Stock or it is determined after the delivery of Common Stock to you that the amount of the Company’s withholding obligation was greater than the amount withheld by the Company, you agree to indemnify and hold the Company harmless from
any failure by the Company to withhold the proper amount. 
 12. TAX CONSEQUENCES. The Company has no
duty or obligation to minimize the tax consequences to you of this Award and shall not be liable to you for any adverse tax consequences to you arising in connection with this Award. You are hereby advised to consult with your own personal tax,
financial and/or legal advisors regarding the tax consequences of this Award and by signing the Grant Notice, you have agreed that you have done so or knowingly and voluntarily declined to do so. You understand that you (and not the Company) shall
be responsible for your own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement. 

13. UNSECURED OBLIGATION. Your Award is unfunded, and as a holder of a vested Award, you shall be
considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares or other property pursuant to this Agreement. You shall not have voting or any other rights as a stockholder of the Company with
respect to the shares to be issued pursuant to this Agreement until such shares are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company. Nothing
contained in this Agreement, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person. 

14. NOTICES. Any notice or request required or permitted hereunder shall be given in writing to each of the other
parties hereto and shall be deemed effectively given on the earlier of (i) the date of personal delivery, including delivery by express courier, or delivery via electronic means, or (ii) the date that is five (5) days after deposit in
the United States Post Office (whether or not actually received by the addressee), by registered or certified mail with postage and fees prepaid, addressed at the following addresses, or at such other address(es) as a party may designate by ten
(10) days’ advance written notice to each of the other parties hereto: 
  

			
	COMPANY:	  	TriVascular Technologies, Inc.
		  	Attn: [Stock Administrator]
		  	3910 Brickway Blvd.
		  	Santa Rosa, CA 95403
		
	PARTICIPANT:	  	Your address as on file with the Company at the time notice is given.


  
 4 








 15. MISCELLANEOUS. 

(a) The rights and obligations of the Company under your Award shall be transferable by the Company to any one or more persons or
entities, and all covenants and agreements hereunder shall inure to the benefit of, and be enforceable by, the Company’s successors and assigns. 

(b) You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the
Company to carry out the purposes or intent of your Award. 
 (c) You acknowledge and agree that you have reviewed your Award in its
entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award and fully understand all provisions of your Award. 

(d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies
or national securities exchanges as may be required. 
 (e) All obligations of the Company under the Plan and this Agreement shall be
binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. 

16. GOVERNING PLAN DOCUMENT. Your Award is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. Your Award (and any compensation
paid or shares issued under your Award) is subject to recoupment in accordance with The Dodd–Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company and any
compensation recovery policy otherwise required by applicable law. No recovery of compensation under such a clawback policy will be an event giving rise to a right to voluntarily terminate employment upon a resignation for “good reason,”
or for a “constructive termination” or any similar term under any plan of or agreement with the Company. 
 17.
EFFECT ON OTHER EMPLOYEE BENEFIT PLANS. The value of the Award subject to this Agreement shall not be included as compensation, earnings, salaries, or
other similar terms used when calculating benefits under any employee benefit plan (other than the Plan) sponsored by the Company or any Affiliate except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend,
modify, or terminate any or all of the employee benefit plans of the Company or any Affiliate. 
 18.
SEVERABILITY. If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of this
Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such
Section or part of a Section to the fullest extent possible while remaining lawful and valid. 
 19. OTHER
DOCUMENTS. You hereby acknowledge receipt or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act. In addition, you acknowledge receipt of the Company’s
Insider Trading Policy and Code of Conduct and Ethics, as in effect from time to time. 

  
 5 








 20. AMENDMENT. This Agreement may not be modified, amended
or terminated except by an instrument in writing, signed by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which specifically states that it
is amending this Agreement, so long as a copy of such amendment is delivered to you, and provided that, except as otherwise expressly provided in the Plan, no such amendment materially adversely affecting your rights hereunder may be made without
your written consent. Without limiting the foregoing, the Board reserves the right to change, by written notice to you, the provisions of this Agreement in any way it may deem necessary or advisable to carry out the purpose of the Award as a result
of any change in applicable laws or regulations or any future law, regulation, ruling, or judicial decision, provided that any such change shall be applicable only to rights relating to that portion of the Award which is then subject to restrictions
as provided herein. 
 21. COMPLIANCE WITH SECTION 409A OF
THE CODE. This Award is intended to comply with the “short-term deferral” rule set forth in Treasury Regulation Section 1.409A-1(b)(4). Notwithstanding the foregoing, if it is determined that the
Award fails to satisfy the requirements of the short-term deferral rule and is otherwise deferred compensation subject to Section 409A, and if you are a “Specified Employee” (within the meaning set forth in
Section 409A(a)(2)(B)(i) of the Code) as of the date of your “separation from service” (within the meaning of Treasury Regulation Section 1.409A-1(h) and without regard to any alternative definition thereunder), then the issuance
of any shares that would otherwise be made upon the date of the separation from service or within the first six (6) months thereafter will not be made on the originally scheduled date(s) and will instead be issued in a lump sum on the date that
is six (6) months and one day after the date of the separation from service, with the balance of the shares issued thereafter in accordance with the original vesting and issuance schedule set forth above, but if and only if such delay in the
issuance of the shares is necessary to avoid the imposition of adverse taxation on you in respect of the shares under Section 409A of the Code. Each installment of shares that vests is intended to constitute a “separate payment” for
purposes of Treasury Regulation Section 1.409A-2(b)(2). 
 ***** 

This Restricted Stock Unit Award Agreement shall be deemed to be signed by the Company and the Participant upon the signing by the Participant
of the Restricted Stock Unit Grant Notice to which it is attached. 

  
 6 








 ATTACHMENT II 

2014 Equity Incentive Plan 

  
 7 








 TRIVASCULAR TECHNOLOGIES, INC. 2014 

EQUITY INCENTIVE PLAN 

RESTRICTED STOCK BONUS GRANT NOTICE 

TRIVASCULAR TECHNOLOGIES, INC. (the “Company”),
pursuant to its 2014 Equity Incentive Plan (the “Plan”), hereby awards to Participant a restricted stock bonus for the number of shares of the Company’s Common Stock set forth below (the “Award”).
The Award is subject to all of the terms and conditions as set forth in this notice of grant, the Restricted Stock Bonus Agreement (the “Award Agreement”), the Plan, the form of Assignment Separate from Certificate and the
form of Joint Escrow Instructions, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meanings set forth in the Plan or the Award Agreement. In the event of any
conflict between the terms in the Award and the Plan, the terms of the Plan shall control. 
  

					
	Participant:	  	  

	Date of Grant:	  	  

	Vesting Commencement Date:	  	  

	 Number of Shares Subject to Award:
	  	  

	Consideration:	  	 Participant’s Past Services


  

			
	Vesting Schedule:	  	 The shares subject to the Award shall vest as follows:

                          
                                         
                                         
                                         
                   .


 Additional Terms/Acknowledgements: The undersigned Participant acknowledges receipt of, and understands and agrees to,
this Restricted Stock Bonus Grant Notice, the Award Agreement and the Plan. Participant further acknowledges that as of the Date of Grant, this Restricted Stock Bonus Grant Notice, the Award Agreement and the Plan set forth the entire understanding
between Participant and the Company regarding the acquisition of stock in the Company and supersede all prior oral and written agreements on that subject with the exception of (i) Awards previously granted and delivered to Participant under the
Plan, and (ii) the following agreements only: 
  

			
	Other Agreements (if any):	 	  

	  

	  


 Participant consents to receive Plan documents by electronic delivery and to participate in the Plan through an on-line or
electronic system established and maintained by the Company or another third party designated by the Company. 
  

									
	TRIVASCULAR TECHNOLOGIES, INC.	 		 	PARTICIPANT:
				
	By:	 	  
	 		 	  

		 	Signature	 		 		 	Signature
					
	Title:	 	  
	 		 	Date:	 	  

					
	Date:	 	  
	 		 		 	

 ATTACHMENTS: Restricted Stock Bonus Agreement, 2014 Equity Incentive Plan, form of
Assignment Separate from Certificate and form of Joint Escrow Instructions. 







 ATTACHMENT I 

TRIVASCULAR TECHNOLOGIES, INC. 

2014 EQUITY INCENTIVE PLAN 

RESTRICTED STOCK BONUS AGREEMENT 

Pursuant to your Restricted Stock Bonus Grant Notice (“Grant Notice”) and this Restricted Stock Bonus Agreement (the
“Agreement”), and in consideration of your past services, TRIVASCULAR TECHNOLOGIES, INC. (the “Company”) has awarded you
(“Participant”) a stock bonus (the “Award”) under its 2014 Equity Incentive Plan (the “Plan”) for the number of shares of the Company’s Common Stock indicated in your Grant
Notice. Defined terms not explicitly defined in this Agreement or the Grant Notice shall have the same definitions as in the Plan. The terms of your Award, in addition to those set forth in the Grant Notice, are as follows. 

The details of your Award are as follows: 

1. VESTING. Subject to the limitations contained herein, your Award will vest as provided in the Grant Notice, provided
that vesting will cease upon the termination of your Continuous Service. 
 2. NUMBER OF
SHARES. The number of shares subject to your Award may be adjusted from time to time for Capitalization Adjustments, as provided in the Plan. 

3. SECURITIES LAW COMPLIANCE. You may not be issued any shares under your Award unless the
shares of Common Stock underlying the Restricted Stock Units are either (i) then registered under the Securities Act, or (ii) the Company has determined that such issuance would be exempt from the registration requirements of the
Securities Act. Your Award must also comply with other applicable laws and regulations governing the Award, and you shall not receive such Common Stock if the Company determines that such receipt would not be in material compliance with such laws
and regulations. 
 4. RIGHT OF REACQUISITION. T he Company shall have the right to
reacquire all or any part of the shares received pursuant to your Award (a “Reacquisition Right”) as to the shares you received pursuant to your Award that have not as yet vested in accordance with the Vesting Schedule on the
Grant Notice (“Unvested Shares”) on the following terms and conditions: 
 The Company, shall simultaneously with
termination of your Continuous Service automatically reacquire for no consideration (that is, for zero dollars ($0)) all of the Unvested Shares, unless the Company agrees to waive its Reacquisition Right as to some or all of the Unvested Shares. Any
such waiver shall be exercised by the Company by written notice to you or your representative (with a copy to the Escrow Holder as defined below) within ninety (90) days after the termination of your Continuous Service, and the Escrow Holder
may then release to you the number of Unvested Shares not being reacquired by the Company. If the Company does not waive its Reacquisition Right as to all of the Unvested Shares, then upon such termination of your Continuous Service, the Escrow
Holder shall transfer to the Company the number of shares the Company is reacquiring. 
 The shares issued under your Award shall be held in
escrow pursuant to the terms of the Joint Escrow Instructions attached to the Grant Notice as Attachment IV. You agree to execute two (2) Assignment Separate From Certificate forms (with date and number of shares blank) substantially in the
form attached to the Grant Notice as Attachment III and deliver the same, along with the certificate or certificates evidencing the shares, for use by the escrow agent pursuant to the terms of the Joint Escrow Instructions. 







 Subject to the provisions of your Award, you shall, during the term of your Award, exercise all
rights and privileges of a stockholder of the Company with respect to the shares deposited in escrow. You shall be deemed to be the holder of the shares for purposes of receiving any dividends which may be paid with respect to such shares (which
shall be subject to the same vesting and forfeiture restrictions as apply to the shares to which they relate) and for purposes of exercising any voting rights relating to such shares, even if some or all of such shares have not yet vested and been
released from the Company’s Reacquisition Right. 
 If, from time to time, there is any stock dividend, stock split or other change in
the character or amount of any of the outstanding stock of the corporation the stock of which is subject to the provisions of your Award, then in such event any and all new, substituted or additional securities to which you are entitled by reason of
your ownership of the shares acquired under your Award shall be immediately subject to the Reacquisition Right with the same force and effect as the shares subject to this Reacquisition Right immediately before such event. 

In addition to any other limitation on transfer created by applicable securities laws, you shall not sell, assign, hypothecate, donate,
encumber, or otherwise dispose of any interest in the Common Stock while such shares of Common Stock are subject to the Reacquisition Right or continue to be held in the Joint Escrow; provided, however, that an interest in such shares may be
transferred pursuant to a qualified domestic relations order as defined in the Code or Title I of the Employee Retirement Income Security Act. 

5. RESTRICTIVE LEGENDS. The shares issued under your Award shall be endorsed with appropriate legends
determined by the Company. 
 6. AWARD NOT A SERVICE
CONTRACT. Nothing in this Agreement (including, but not limited to, the vesting of your Award), the Plan or any covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan shall:
(i) confer upon you any right to continue in the employ of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future
work assignments, future compensation or any other term or condition of employment or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this
Agreement or Plan; or (iv) deprive the Company of the right to terminate you at will and without regard to any future vesting opportunity that you may have. 

7. WITHHOLDING OBLIGATIONS. At the time your Award is made, or at any time thereafter as requested by the
Company, you hereby authorize withholding from payroll and any amounts payable to you, and otherwise agree to make adequate provision for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company
or an Affiliate, if any, which arise in connection with your Award. Unless the tax withholding obligations of the Company and/or any Affiliate are satisfied, the Company shall have no obligation to issue a certificate for such shares or release such
shares from any escrow provided for herein. 
 8. TAX CONSEQUENCES. The acquisition and vesting of the
shares may have adverse tax consequences to you that may avoided or mitigated by filing an election under Section 83(b) of the Code. Such election must be filed within thirty (30) days after the date of your Award. YOU ACKNOWLEDGE THAT IT
IS YOUR OWN RESPONSIBILITY, AND NOT THE COMPANY’S, TO FILE A TIMELY ELECTION UNDER CODE SECTION 83(b), EVEN IF YOU REQUEST THE COMPANY TO MAKE THE FILING ON YOUR BEHALF. 

  
 2 








 9. NOTICES. Any notices provided for in your option or the Plan will be
given in writing (including electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed
to you at the last address you provided to the Company. The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by electronic means or to request your consent to participate in the
Plan by electronic means. By accepting this Award, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party
designated by the Company. 
 10. MISCELLANEOUS. 

(a) The rights and obligations of the Company under your Award shall be transferable by the Company to any one or more persons or
entities, and all covenants and agreements hereunder shall inure to the benefit of, and be enforceable by, the Company’s successors and assigns. Your rights and obligations under your Award may only be assigned with the prior written consent of
the Board in its sole discretion. 
 (b) You agree upon request to execute any further documents or instruments necessary or
desirable in the sole determination of the Company to carry out the purposes or intent of your Award. 
 (c) You acknowledge and
agree that you have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award and fully understand all provisions of your Award. 

(d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies
or national securities exchanges as may be required. 
 (e) All obligations of the Company under the Plan and this Agreement shall be
binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. 

11. GOVERNING PLAN DOCUMENT. Your Award is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict
between the provisions of your Award and those of the Plan, the provisions of the Plan shall control. 
 12.
SEVERABILITY. If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of this
Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such
Section or part of a Section to the fullest extent possible while remaining lawful and valid. 
 13. OTHER
DOCUMENTS. You hereby acknowledge receipt or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act. In addition, you acknowledge receipt of the Company’s
Insider Trading Policy and Code of Conduct and Ethics, as in effect from time to time. 

  
 3 








 ***** 

This Restricted Stock Bonus Agreement shall be deemed to be signed by the Participant upon the signing by the Participant of the Restricted
Stock Bonus Grant Notice to which it is attached. 

  
 4 








 ATTACHMENT II  

2014 EQUITY INCENTIVE PLAN 

  
 5 








 Attachment III 

STOCK ASSIGNMENT SEPARATE FROM CERTIFICATE 

FOR VALUE RECEIVED,              hereby sells, assigns and transfers unto
TRIVASCULAR TECHNOLOGIES, INC., a Delaware corporation (the “Company”), pursuant to the Reacquisition Right under that certain Restricted Stock Bonus Agreement, dated
                 , 20     by and between the undersigned and the Company (the “Agreement”),
                     shares of Common Stock of the Company standing in the undersigned’s name on the books of the Company [represented by
Certificate No(s).                     ] and does hereby irrevocably constitute and appoint the Company’s Secretary as attorney-in-fact to
transfer said Common Stock on the books of the Company with full power of substitution in the premises. This Assignment may be used only in accordance with and subject to the terms and conditions of the Agreement, in connection with the repurchase
of shares of Common Stock issued to the undersigned pursuant to the Agreement, and only to the extent that such shares remain subject to the Company’s Reacquisition Right under the Agreement. 

Dated:                     , 20    

  

	
	  

	(Signature)
	
	  

	(Print Name)


 (INSTRUCTION: Please do not fill in any blanks other than the “Signature” line and the “Print
Name” line.) 

  
 6 








 ATTACHMENT III 

JOINT ESCROW INSTRUCTIONS 
 Corporate Secretary

 TRIVASCULAR TECHNOLOGIES, INC. 
 3910 Brickway Blvd. 

Santa Rosa, California 95403 
 Dear Sir or Madam: 

As Escrow Agent for both TriVascular Technologies, Inc., a Delaware corporation (the “Company”), and the undersigned
recipient of stock of the Company (“Recipient”), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Bonus Grant Notice (the “Grant
Notice”), dated to which a copy of these Joint Escrow Instructions is attached as Attachment IV, and pursuant to the terms of that certain Restricted Stock Bonus Agreement (“Agreement”), which is Attachment I to
the Grant Notice, in accordance with the following instructions. Capitalized terms not explicitly defined in these instructions but defined in the Company’s 2014 Equity Incentive Plan (“Plan”), the Grant Notice, or the
Agreement shall have the same definitions as provided therein: 
 1. In the event Recipient ceases to render services to the Company
or an affiliate of the Company during the vesting period set forth in the Grant Notice, the Company or its assignee will give to Recipient and you a written notice specifying that the shares of Common Stock shall be transferred to the Company.
Recipient and the Company hereby irrevocably authorize and direct you to close the transaction contemplated by such notice in accordance with the terms of said notice. 

2. At the closing you are directed (a) to date any stock assignments necessary for the transfer in question, (b) to fill in
the number of shares being transferred, and (c) to deliver same, together with the certificate evidencing the shares of Common Stock to be transferred, to the Company. 

3. Recipient irrevocably authorizes the Company to deposit with you any certificates evidencing shares of Common Stock to be held by
you hereunder and any additions and substitutions to said shares as specified in the Grant Notice. Recipient does hereby irrevocably constitute and appoint you as Recipient’s attorney-in-fact and agent for the term of this escrow to execute
with respect to such securities and other property all documents of assignment and/or transfer and all stock certificates necessary or appropriate to make all securities negotiable and complete any transaction herein contemplated. 

4. This escrow shall terminate upon vesting of the shares or upon the earlier return of the shares to the Company pursuant to the
Company’s Reacquisition Right or other forfeiture condition under the Plan. 
 5. If at the time of termination of this escrow
you should have in your possession any documents, securities, or other property belonging to Recipient, you shall deliver all of same to any pledgee entitled thereto or, if none, to Recipient and shall be discharged of all further obligations
hereunder. 
 6. Except as otherwise provided in these Joint Escrow Instructions, your duties hereunder may be altered, amended,
modified or revoked only by a writing signed by all of the parties hereto. 

  
 7 








 7. You shall be obligated only for the performance of such duties as are specifically set
forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties or their assignees. You shall not be
personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Recipient while acting in good faith and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive
evidence of such good faith. 
 8. You are hereby expressly authorized to disregard any and all warnings given by any of the parties
hereto or by any other person or corporation, excepting only orders or process of courts of law, and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order,
judgment or decree of any court, you shall not be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified,
annulled, set aside, vacated or found to have been entered without jurisdiction. 
 9. You shall not be liable in any respect on
account of the identity, authority or rights of the parties executing or delivering or purporting to execute or deliver the Grant Notice or any documents or papers deposited or called for hereunder. 

10. You shall not be liable for the outlawing of any rights under any statute of limitations with respect to these Joint Escrow
Instructions or any documents deposited with you. 
 11. You shall be entitled to employ such legal counsel, including but not
limited to Arnold & Porter, LLP, and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation
therefor. 
 12. Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be Secretary of the Company or
if you shall resign by written notice to each party. In the event of any such termination, the Company may appoint any officer or assistant officer of the Company as successor Escrow Agent and Recipient hereby confirms the appointment of such
successor or successors as his attorney-in-fact and agent to the full extent of your appointment. 
 13. If you reasonably require
other or further instruments in connection with these Joint Escrow Instructions or obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments. 

14. It is understood and agreed that should any dispute arise with respect to the delivery and/or ownership or right of possession of
the securities, you may (but are not obligated to) retain in your possession without liability to anyone all or any part of said securities until such dispute shall have been settled either by mutual written agreement of the parties concerned or by
a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings. 

  
 8 








 15. Any notice required or permitted hereunder shall be given in writing and shall be
deemed effectively given upon personal delivery or upon deposit in any United States Post Box, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties hereunto entitled at the following addresses, or at
such other addresses as a party may designate by ten (10) days’ written notice to each of the other parties hereto: 
  

					
	COMPANY:	  	 TriVascular Technologies, Inc.
 3910 Brickway
Blvd.
 Santa Rosa, California 95403
	  	
			
	RECIPIENT:	  	  
	  	
		  	  
	  	
			
	ESCROW AGENT:	  	 Corporate Secretary
 TriVascular
Technologies, Inc.
 3910 Brickway Blvd.
 Santa Rosa, California
95403
	  	

 16. By signing these Joint Escrow Instructions you become a party hereto only for the purpose of said
Joint Escrow Instructions; you do not become a party to the Grant Notice. 
 17. This instrument shall be binding upon and inure to
the benefit of the parties hereto, and their respective successors and permitted assigns. It is understood and agreed that references to “you” or “your” herein refer to the original Escrow Agent and to any and all successor
Escrow Agents. It is understood and agreed that the Company may at any time or from time to time assign its rights under the Grant Notice and these Joint Escrow Instructions in whole or in part. 

18. This Agreement shall be governed by and interpreted and determined in accordance with the laws of the State of California, as such
laws are applied by California courts to contracts made and to be performed entirely in California by residents of that state. 
  

			
	Very truly yours,
	
	TRIVASCULAR TECHNOLOGIES, INC.:
		
	By:	 	  

	Title:	 	
		 	 Address:

	 3910 Brickway Blvd.
 Santa Rosa,
California 95403



  

			
	RECIPIENT:
	
	  

	Signature
		
	Address:	 	  



 

	
	ESCROW AGENT:
	
	  




  
 9